SPAGO NANOMEDICAL AB

Insiders Spago Nanomedical AB

Equities

SPAGO

SE0004899474

Market Closed - Nasdaq Stockholm Other stock markets 05:44:03 2024-05-08 EDT			5-day change	1st Jan Change
0.283 ^SEK	-4.39%		-23.10%	-13.46%

04-24	Spago Nanomedical AB Reports Favorable Data in Breast Cancer Model with Tumorad	CI
04-16	Spago Nanomedical AB Announces Appointment of Birgitta Rembratt Svensson as Head of CMC & Supply, Effective June 1, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spago Nanomedical AB Announces Appointment of Birgitta Rembratt Svensson as Head of CMC & Supply, Effective June 1, 2024	04-16	CI
Spago Nanomedical AB Announces Establishment of A Scientific Advisory Board	23-06-13	CI
Spago Nanomedical AB Elects New Directors	23-05-10	CI
Spago Nanomedical AB Announces Board Resignations	23-04-05	CI
The nomination committee proposes changes to the board of Spago Nanomedical for increased commercial focus	23-04-04	AQ
Nomination committee appointed for the 2023 Annual General Meeting in Spago Nanomedical	22-10-20	AQ
Spago Nanomedical : Nomination committee appointed for the 2022 Annual General Meeting in Spago Nanomedical	21-10-21	AQ
Spago Nanomedical AB Appoints Paul Hargreaves as Chief Development Officer	21-08-03	CI
Spago Nanomedical AB Appoints Candidate Drug in the Tumorad® Project	20-08-24	CI
Spago Nanomedical Approves Appointment of Peter Wulff to its Board of Directors Replacing Jörgen Buus Lassen	16-04-19	CI
Spago Imaging AB Appoints Eva Redhe Ridderstad as Chairman of the Board	12-11-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW